ArticleClinical journal of gastroenterology2026
Durable disease control in unresectable hepatocellular carcinoma with atezolizumab plus half-dose bevacizumab: pathological complete response of peritoneal metastasis.
Haruki Mori et al.PubMed ↗Publisher ↗
No numbers read from the abstract.